Balchem Corporation is a specialty chemicals business based in the US. Balchem Corporation shares (BCPC) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $162.74 – an increase of 4.31% over the previous week. Balchem Corporation employs 1,379 staff and has a trailing 12-month revenue of around $964.5 million.
The Finder Score crunches 147 key metrics we collected directly from 18+ brokers and assessed each provider’s performance based on nine different categories, weighing each metric based on the expertise and insights of Finder’s investment experts. We then scored and ranked each provider to determine the best brokerage accounts.
We update our best picks as products change, disappear or emerge in the market. We also regularly review and revise our selections to ensure our best provider lists reflect the most competitive available.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
| Latest market close | $162.74 |
|---|---|
| 52-week range | $145.70 - $185.06 |
| 50-day moving average | $163.90 |
| 200-day moving average | $168.50 |
| Wall St. target price | $196.67 |
| PE ratio | 38.7249 |
| Dividend yield | $0.87 (0.54%) |
| Earnings per share (TTM) | $4.18 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $161.87 from 2025-05-02
| 1 week (2025-04-28) | 3.70% |
|---|---|
| 1 month (2025-04-04) | 3.91% |
| 3 months (2025-02-06) | -1.51% |
| 6 months (2024-11-06) | -11.74% |
| 1 year (2024-05-06) | 5.58% |
|---|---|
| 2 years (2023-05-05) | 27.69% |
| 3 years (2022-05-05) | 36.75% |
| 5 years (2020-05-05) | 93.60% |
Valuing Balchem Corporation stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Balchem Corporation's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Balchem Corporation's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 39x. In other words, Balchem Corporation shares trade at around 39x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Balchem Corporation's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 3.6341. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Balchem Corporation's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Balchem Corporation's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $238.4 million.
The EBITDA is a measure of a Balchem Corporation's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $964.5 million |
|---|---|
| Operating margin TTM | 20.56% |
| Gross profit TTM | $342.9 million |
| Return on assets TTM | 7.54% |
| Return on equity TTM | 11.94% |
| Profit margin | 14.16% |
| Book value | $37.06 |
| Market Capitalization | $5.3 billion |
TTM: trailing 12 months
Dividend payout ratio: 19.04% of net profits
Recently Balchem Corporation has paid out, on average, around 0% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Balchem Corporation shareholders could enjoy a 0% return on their shares, in the form of dividend payments. In Balchem Corporation's case, that would currently equate to about $0.87 per share.
While Balchem Corporation's payout ratio might seem low, this can signify that Balchem Corporation is investing more in its future growth.
Balchem Corporation's most recent dividend payout was on 16 January 2025. The latest dividend was paid out to all shareholders who bought their shares by 25 December 2024 (the "ex-dividend date").
Balchem Corporation's shares were split on a 3:2 basis on 20 January 2010 . So if you had owned 2 shares the day before before the split, the next day you'd have owned 3 shares. This wouldn't directly have changed the overall worth of your Balchem Corporation shares – just the quantity. However, indirectly, the new 33.3% lower share price could have impacted the market appetite for Balchem Corporation shares which in turn could have impacted Balchem Corporation's share price.
Over the last 12 months, Balchem Corporation's shares have ranged in value from as little as $145.7 up to $185.0618. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Balchem Corporation's is 0.753. This would suggest that Balchem Corporation's shares are less volatile than average (for this exchange).
Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment offers specialty vitamin K2; microencapsulation solutions for various applications; and human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. The Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production and delivering nutrient supplements in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; methylsulfonylmethane; and choline chloride, a nutrient for monogastric animal health. The Specialty Products segment distributes ethylene oxide and ammonia primarily for use in the health care industry; and single use canisters for sterilizing re-usable devices.
Track the progress of the S&P 500 stocks to make more informed investment decisions.
See our picks for the best brokers for trading S&P 500 stocks, ETFs, options and futures.
These are the stocks to buy when you don’t have much to spend.
Some of the best stock trading apps for beginners include SoFi, Robinhood, Public, Stash, Opto and more. Compare your options here.
Compare pros, cons, research tools and reviews for these two trading platforms.
Check out our picks of the best trading apps for beginners, options traders, hands-off investors and more.
Some of the best trading apps like Robinhood are SoFi, Tastytrade, Public, eToro, Acorns, Interactive Brokers, E*TRADE and more.
Compare pros, cons, research tools and reviews for these two trading platforms.
See our picks of the best brokerage accounts, including Fidelity, SoFi, Charles Schwab, Public, Robinhood and E*TRADE .
SoFi Invest is a no-fee commissions platform with both active and automated investment accounts.